Multiple Sclerosis May Worsen With Menopause Transition
By Lori Solomon HealthDay Reporter
FRIDAY, Jan. 24, 2025 -- The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, according to a study published online Dec. 23 in Neurology.
Hannah E. Silverman, from the University of California San Francisco, and colleagues assessed the trajectory of objective functional outcomes and disease biomarkers in women with MS before and after menopause. The analysis included 184 postmenopausal women with MS followed for a median of 13 years.
The researchers found that the median age at natural menopause was 50 years (range, 33 to 60 years) and that 17 percent of participants used any systemic menopausal hormone therapy. The Multiple Sclerosis Functional Composite (MSFC) reached a worsening inflection point with menopause (slope difference, 0.08) and an increase in serum neurofilament light chain (slope difference, −0.95). For the Expanded Disability Status Scale (EDSS), the opposite was found (slope difference, 0.05). Significant findings persisted when adjusting for multiple covariates. Similar inflection points were found (within three years of the final menstrual period) for serum neurofilament light chain and EDSS but not MSFC when using additional nonlinear regression modeling.
"These findings suggest that further inquiry into the possible neurobiological effects of this major hormonal transition is warranted. Indeed, our results imply that changes in gonadal hormones may be associated with changes in functional and biological markers in MS," the authors write. "Further research should investigate possible clinical implications, including need for more targeted disease, symptom, and rehabilitation management around the time of menopause."
This analysis was supported through an investigator-initiated study sponsored by Genentech.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Survey Reveals Women May Be Experiencing Perimenopause in Their 40s
FRIDAY, April 25, 2025 -- Six in 10 women believe they will hit menopause in their 40s, according to survey results released April 8 by The Ohio State University Wexner Medical...
AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS
WEDNESDAY, April 9, 2025 -- Tolebrutinib, a brain-penetrant and bioactive Bruton tyrosine kinase inhibitor that modulates persistent immune activation within the central nervous...
Common Photosensitizing Drugs Increase Skin Cancer Risk
TUESDAY, April 1, 2025 -- Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.